A Novel Perspective on Tau in Alzheimer's Disease

被引:2
|
作者
Bonda, D. J. [3 ]
Castellani, R. J. [4 ]
Zhu, X. [3 ]
Nunomura, A. [5 ]
Lee, H. -g. [3 ]
Perry, G. [1 ,2 ,3 ]
Smith, M. A. [3 ]
机构
[1] Univ Texas San Antonio, Coll Sci, UTSA Neurosci Inst, San Antonio, TX 78249 USA
[2] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA
[3] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA
[4] Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA
[5] Univ Yamanashi, Dept Neuropsychiat, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi 4093898, Japan
基金
美国国家卫生研究院;
关键词
Alzheimer disease; neuron; oxidative stress; phosphorylation; tau; PAIRED HELICAL FILAMENTS; LIPID-PEROXIDATION PRODUCT; ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; NEUROFIBRILLARY TANGLES; HYPERPHOSPHORYLATED TAU; AMYLOID-BETA; P38; KINASE; PHOSPHORYLATION; NEURONS;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mainstream thinking is dominated by the notion that the aggregation of specific proteins within neurons, and their subsequent formation into cytoplasmic and extracellular lesions, directly elicits neuronal dysfunction and death. Current dogma, for example, maintains that phosphorylated tau protein, the major component of neurofibrillary tangles, is a central mediator of disease pathogenesis. In this article, we challenge this classic notion by proposing that tau phosphorylation represents a compensatory response mounted by neurons against oxidative stress that serves a protective function. This concept provides a better understanding of the mechanisms underlying disease pathophysiology and also provides a window for therapeutic intervention.
引用
收藏
页码:639 / 642
页数:4
相关论文
共 50 条
  • [41] IN VIVO TAU IMAGING IN ALZHEIMER'S DISEASE
    Villemagne, Victor L.
    Furumoto, Shozo
    Fodero-Tavoletti, Michelle T.
    Mulligan, Rachel S.
    Harada, Ryuichi
    Yanai, Kazuhiko
    Masters, Colin L.
    Kudo, Yukitsuka
    Rowe, Christopher C.
    Okamura, Nobuyuki
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 4 - 4
  • [42] Tau is actin up in Alzheimer's disease
    Gianluca Gallo
    Nature Cell Biology, 2007, 9 : 133 - 134
  • [43] In vivo tau staging in Alzheimer's disease
    Therriault, Joseph
    Gauthier, Serge
    Rosa-Neto, Pedro
    AGING-US, 2022, 14 (17): : 6842 - 6843
  • [44] Plasma tau levels in Alzheimer's disease
    Henrik Zetterberg
    David Wilson
    Ulf Andreasson
    Lennart Minthon
    Kaj Blennow
    Jeffrey Randall
    Oskar Hansson
    Alzheimer's Research & Therapy, 5
  • [45] Alzheimer's disease:: Aβ, tau and synaptic dysfunction
    LaFerla, FM
    Oddo, S
    TRENDS IN MOLECULAR MEDICINE, 2005, 11 (04) : 170 - 176
  • [46] Plasma tau levels in Alzheimer's disease
    Zetterberg, Henrik
    Wilson, David
    Andreasson, Ulf
    Minthon, Lennart
    Blennow, Kaj
    Randall, Jeffrey
    Hansson, Oskar
    ALZHEIMERS RESEARCH & THERAPY, 2013, 5 (02):
  • [47] Targeting Tau Protein in Alzheimer’s Disease
    Cheng-Xin Gong
    Inge Grundke-Iqbal
    Khalid Iqbal
    Drugs & Aging, 2010, 27 : 351 - 365
  • [48] Tau as a Therapeutic Target for Alzheimer's Disease
    Boutajangout, A.
    Sigurdsson, E. M.
    Krishnamurthy, P. K.
    CURRENT ALZHEIMER RESEARCH, 2011, 8 (06) : 666 - 677
  • [49] Tau polymorphisms are not associated with Alzheimer's disease
    Kwon, JM
    Nowotny, P
    Shah, PK
    Chakraverty, S
    Norton, J
    Morris, JC
    Goate, AM
    NEUROSCIENCE LETTERS, 2000, 284 (1-2) : 77 - 80
  • [50] Tau PET Imaging in Alzheimer's Disease
    Okamura, Nobuyuki
    Harada, Ryuichi
    Furumoto, Shozo
    Arai, Hiroyuki
    Yanai, Kazuhiko
    Kudo, Yukitsuka
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2014, 14 (11)